MetLife, Inc. (NYSE:MET) Shares Sold by Jennison Associates LLC

Jennison Associates LLC lessened its stake in MetLife, Inc. (NYSE:MET - Free Report) by 42.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,462,629 shares of the financial services provider's stock after selling 1,060,099 shares during the quarter. Jennison Associates LLC owned 0.20% of MetLife worth $96,724,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in MET. Dynamic Advisor Solutions LLC acquired a new stake in shares of MetLife during the 3rd quarter worth about $303,000. CWM LLC raised its stake in shares of MetLife by 10.4% during the third quarter. CWM LLC now owns 9,758 shares of the financial services provider's stock valued at $614,000 after purchasing an additional 918 shares during the period. Global Retirement Partners LLC raised its stake in shares of MetLife by 6.3% during the third quarter. Global Retirement Partners LLC now owns 6,536 shares of the financial services provider's stock valued at $392,000 after purchasing an additional 390 shares during the period. HB Wealth Management LLC increased its stake in shares of MetLife by 33.1% in the third quarter. HB Wealth Management LLC now owns 9,191 shares of the financial services provider's stock worth $578,000 after buying an additional 2,286 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of MetLife by 15.2% in the third quarter. SG Americas Securities LLC now owns 47,646 shares of the financial services provider's stock worth $2,997,000 after buying an additional 6,294 shares during the last quarter. Hedge funds and other institutional investors own 89.81% of the company's stock.


Wall Street Analyst Weigh In

A number of equities analysts have commented on MET shares. The Goldman Sachs Group raised shares of MetLife from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $70.00 to $80.00 in a report on Monday, January 8th. Wells Fargo & Company upped their price target on shares of MetLife from $83.00 to $86.00 and gave the stock an "overweight" rating in a research report on Thursday, April 11th. Morgan Stanley upped their price target on shares of MetLife from $80.00 to $82.00 and gave the stock an "overweight" rating in a research report on Monday, April 15th. Piper Sandler upped their price target on shares of MetLife from $74.00 to $85.00 and gave the stock an "overweight" rating in a research report on Friday, April 5th. Finally, UBS Group lowered their price target on shares of MetLife from $87.00 to $82.00 and set a "buy" rating for the company in a research report on Monday, February 5th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, MetLife presently has an average rating of "Moderate Buy" and a consensus price target of $79.23.

View Our Latest Report on MetLife

Insider Buying and Selling

In other MetLife news, insider Ramy Tadros sold 4,026 shares of the stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the transaction, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, insider Ramy Tadros sold 4,026 shares of the stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares of the company's stock, valued at $10,567,933.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Bill Pappas sold 27,000 shares of the firm's stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the transaction, the executive vice president now directly owns 57,768 shares of the company's stock, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

MetLife Price Performance

NYSE MET traded up $0.27 on Tuesday, reaching $72.23. The company's stock had a trading volume of 2,106,196 shares, compared to its average volume of 3,531,897. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a twelve month low of $48.95 and a twelve month high of $74.68. The stock has a market cap of $52.22 billion, a PE ratio of 39.45, a PEG ratio of 0.53 and a beta of 1.04. The firm's 50 day moving average is $71.19 and its two-hundred day moving average is $66.94.

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts' consensus estimates of $1.95 by ($0.02). The firm had revenue of $18.72 billion for the quarter, compared to analysts' expectations of $18.07 billion. MetLife had a net margin of 2.36% and a return on equity of 19.48%. As a group, sell-side analysts predict that MetLife, Inc. will post 8.71 EPS for the current year.

MetLife Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 3.02%. This is an increase from MetLife's previous quarterly dividend of $0.52. MetLife's dividend payout ratio is currently 113.66%.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Featured Articles and Offers

Search Headlines: